The listing window in Hong Kong is open. The queue is long.

Hong Kong just posted its strongest first half for new listings in five years. KPMG's mid-year review counts HK$209.9 billion raised across 85 IPOs in the first six months of 2026, up 92 percent on funds raised and 102 percent on deal count against the same period last year. Only Nasdaq raised more. New York came third.

Two things inside that headline matter more than the headline.

The money is concentrated

Twenty-four of those listings were A+H deals, mainland-listed companies adding a Hong Kong line, and they took 58 percent of all funds raised. Another thirteen came through the specialist technology chapter. The wave, in other words, is Chinese hard tech coming to market at scale. A foreign mid-market issuer is not competing with that wave. It is arriving alongside it, into a market where the institutional money is switched on and allocating again.

The queue is real

KPMG counts over 500 active applicants in the pipeline, with publicly filed applications up 52 percent since the start of the year. Bankers, counsel and the exchange's review teams are all working the same stack. For a company that has been circling the idea of an Asian listing, that cuts both ways: the window is demonstrably open, and every quarter of delay puts more filings ahead of yours.

What we tell clients

The exchange decision still has to be argued on the merits. For some companies the answer remains the ASX or a North American board, and we say so. But the pattern we watch for is a business with revenue or ambitions in Asia listing far from its own story. Investors pay for what they can see from their office window. Right now, a lot of them are looking out over Victoria Harbour.

If your board is asking the question, that conversation is worth an hour before it is worth a mandate.

All insights→